Why is Natco Pharma falling/rising?

As of 06-Aug, Natco Pharma Ltd. is experiencing a decline in its stock price, currently at Rs 917.70, reflecting a decrease of Rs 15.15 or 1.62%. The stock has been on a downward trend, having fallen consecutively for the last two days with a total return of -1.88% during this period. Additionally, the stock's performance over the past week shows a decline of 5.91%, and it has underperformed significantly over the year with a return of -31.77%. Despite these declines, the company maintains a high management efficiency with a return on equity (ROE) of 15.57% and a low debt-to-equity ratio, indicating a solid financial position. However, the stock is trading at a discount compared to its peers, which may not be enough to offset the negative sentiment reflected in the recent price movements.
In the broader market context, the Sensex has also seen a decline of 1.15% over the past week, indicating a challenging environment for stocks in general. Natco Pharma's recent performance is notably worse than the benchmark, suggesting that while the pharmaceutical sector has faced a downturn of 2.06%, Natco's struggles are more pronounced. The falling investor participation, with delivery volume decreasing by 36.25% against the five-day average, further highlights a lack of confidence among investors. Despite the company's healthy long-term growth prospects and high institutional holdings, the current market conditions and recent stock performance suggest that investors are cautious, contributing to the stock's decline.